UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024160
Receipt number R000027820
Scientific Title A retrospective analysis of eye disorders induced by chemotherapy including S-1 for Gastrointestinal cancer.
Date of disclosure of the study information 2016/09/26
Last modified on 2016/09/26 00:50:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A retrospective analysis of eye disorders induced by chemotherapy including S-1 for Gastrointestinal cancer.

Acronym

REyeDropS

Scientific Title

A retrospective analysis of eye disorders induced by chemotherapy including S-1 for Gastrointestinal cancer.

Scientific Title:Acronym

REyeDropS

Region

Japan


Condition

Condition

Gastrointestinal cancer

Classification by specialty

Gastroenterology Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This study is conduct to determine the frequency and clinical characteristics of eye disorders induced by chemotherapy including S-1 for Gastrointestinal cancer

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The frequency of eye disorders

Key secondary outcomes

The time to onset and outcome of eye disorders and outcome


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients administered S-1 chemotherapy for gastrointestinal cancer in periods from January, 2008 to May, 2015 at Sapporo City General Hospital

Key exclusion criteria

The case that the dosage situation and side effect information of S-1 cannot confirm from a medical record enough

Target sample size

280


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masataka Yagisawa

Organization

Sapporo City General Hospital

Division name

Department of Gastroenterology

Zip code


Address

1-1, Kita 11, Nishi 13, Chuo, Sapporo, Hokkaido

TEL

080-1104-6869

Email

yagisawa.m@hotmail.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masataka Yagisawa

Organization

Sapporo City General Hospital

Division name

medical office

Zip code


Address

1-1, Kita 11, Nishi 13, Chuo, Sapporo, Hokkaido

TEL

011-726-2211

Homepage URL


Email

yagisawa.m@hotmail.co.jp


Sponsor or person

Institute

Sapporo City General Hospital

Institute

Department

Personal name



Funding Source

Organization

Sapporo City General Hospital

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 09 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2016 Year 09 Month 01 Day

Date of IRB


Anticipated trial start date

2016 Year 09 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2016 Year 09 Month 26 Day

Last modified on

2016 Year 09 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027820


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name